American Heart Journal
Volume 146, Issue 5 , Pages 754-756 , November 2003

New insight into clinical risk scores for patients with acute coronary syndromes

  • David A Morrow, MD, MPH

      Affiliations

    • TIMI Study Group and Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Mass, USA
    • Corresponding Author InformationReprint requests: David A. Morrow, MD, MPH, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

References 

  1. Braunwald E, Antman EM, Beasley JW, et al.  ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—summary article (a report of the ACC/AHA task force on practice guidelines (Committee on the Management of Patients With Unstable Angina)). J Am Coll Cardiol. 2002;40:1366–1374
  2. Braunwald E, Mark D, Jones R, et al. Unstable angina: diagnosis and management. Clinical practice guideline number 10. AHCPR publication no. 94-0602. Rockville (Md): Agency for Health Care Policy and Research and the NHLBI, Public Health Service, US Department of Health and Human Services; 1994:154
  3. Scirica BM, Cannon CP, McCabe CH, et al.  Prognosis in the thrombolysis in myocardial ischemia III registry according to the Braunwald unstable angina pectoris classification. Am J Cardiol. 2002;90:821–826
  4. Jacobs DR, Kroenke C, Crow R, et al.  PREDICT (A simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota heart survey). Circulation. 1999;100:599–607
  5. Boersma E, Pieper KS, Steyerberg EW, et al.  Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation (results from an international trial of 9461 patients. The PURSUIT Investigators). Circulation. 2000;101:2557–2567
  6. Antman EM, Cohen M, Bernink PJ, et al.  The TIMI risk score for unstable angina/non-ST elevation MI (A method for prognostication and therapeutic decision making). JAMA. 2000;284:835–842
  7. Brilakis ES, Wright RS, Kopecky SL, et al. Association of the PURSUIT risk score with predischarge ejection fraction, angiographic severity of coronary artery disease, and mortality in a nonselected, community-based population with non-ST-elevation acute myocardial infarction. Am Heart J 2003;146:811–8
  8. Weintraub WS. Prediction scores after myocardial infarction (value, limitations, and future directions). Circulation. 2002;106:2292–2293
  9. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36
  10. Mathew V, Farkouh M, Grill DE, et al.  Clinical risk stratification correlates with the angiographic extent of coronary artery disease in unstable angina. J Am Coll Cardiol. 2001;37:2053–2058
  11. Morrow DA, Sabatine MS, Cannon CP, et al.  Higher TIMI Risk Score is associated with coronary thrombus and abnormal flow in non-ST elevation acute coronary syndromes (observations from PRISM-PLUS). [abstract] Circulation. 2001;104:II-648
  12. Morrow DA, Antman EM, Snapinn SM, et al.  An integrated clinical approach to predicting the benefit of tirofiban in non-ST eleva-tion acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J. 2002;23:223–229
  13. Singh M, Reeder GS, Jacobsen SJ, et al.  Scores for post-myocardial infarction risk stratification in the community. Circulation. 2002;106:2309–2314
  14. Cannon CP. Evidence-based risk stratification to target therapies in acute coronary syndromes. Circulation. 2002;106:1588–1591
  15. Cannon CP, Weintraub WS, Demopoulos LA, et al.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879–1887
  16. Cannon CP, O'Gara PT. Critical pathway for unstable angina. In:  Cannon CP,  O'Gara PT editor. Critical pathways in cardiology. New York: Lippincott Williams & Wilkins; 2001;p. 131–141
  17. Reilly BM, Evans AT, Schaider JJ, et al.  Impact of a clinical decision rule on hospital triage of patients with suspected acute cardiac ischemia in the emergency department. JAMA. 2002;288:342–350
  18. Morrow DA, Antman EM, Charlesworth A, et al.  TIMI Risk Score for ST-elevation myocardial infarction (a convenient, bedside, clinical score for risk assessment at presentation. An InTIME II substudy). Circulation. 2000;102:2031–2037
  19. Giugliano RP, Llevadot J, Wilcox RG, et al.  Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis (results from InTIME-II). Eur Heart J. 2001;22:1702–1715
  20. Sabatine MS, Morrow DA, Giugliano RP, et al.  Implications of upstream GPIIB/IIIA inhibition and stenting in the invasive management of UA/NSTEMI (a comparison of TIMI IIIB and TACTICS-TIMI 18). [abstract] Circulation. 2001;104:II-549
  21. Krumholz HM, Chen J, Wang Y, et al.  Comparing AMI mortality among hospitals in patients 65 years of age and older (evaluating methods of risk adjustment). Circulation. 1999;99:2986–2992

PII: S0002-8703(03)00460-5

doi: 10.1016/S0002-8703(03)00460-5

American Heart Journal
Volume 146, Issue 5 , Pages 754-756 , November 2003

Article Tools